Published in J Med Virol on September 01, 2007
Entecavir combined with furin inhibitor simultaneously reduces hepatitis B virus replication and e antigen secretion. Virol J (2014) 0.78
Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications. Sci Rep (2015) 0.78
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci U S A (2007) 3.13
Hantavirus in African wood mouse, Guinea. Emerg Infect Dis (2006) 2.49
Novel hantavirus sequences in Shrew, Guinea. Emerg Infect Dis (2007) 2.44
Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion. EMBO J (2003) 1.93
The death-domain fold of the ASC PYRIN domain, presenting a basis for PYRIN/PYRIN recognition. J Mol Biol (2003) 1.61
Single-particle cryoelectron microscopy analysis reveals the HIV-1 spike as a tripod structure. Proc Natl Acad Sci U S A (2010) 1.54
T helper and B cell escape mutations within the HBc gene in patients with asymptomatic HBV infection: a study from the South-Eastern region of Iran. Clin Lab (2012) 1.52
A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses. Vaccine (2002) 1.48
Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis. Gastroenterology (2006) 1.46
Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation. Eur J Immunol (2002) 1.39
High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay. J Clin Microbiol (2002) 1.34
Genetic interaction between distinct Dobrava hantavirus subtypes in Apodemus agrarius and A. flavicollis in nature. J Virol (2003) 1.32
First molecular identification of human Dobrava virus infection in central Europe. J Clin Microbiol (2004) 1.32
Detection and typing of human pathogenic hantaviruses by real-time reverse transcription-PCR and pyrosequencing. Clin Chem (2007) 1.31
Central European Dobrava Hantavirus isolate from a striped field mouse (Apodemus agrarius). J Clin Microbiol (2005) 1.30
Thrombocytopenia and acute renal failure in Puumala hantavirus infections. Emerg Infect Dis (2004) 1.29
The Haemophilus ducreyi cytolethal distending toxin activates sensors of DNA damage and repair complexes in proliferating and non-proliferating cells. Cell Microbiol (2002) 1.26
Occurrence of renal and pulmonary syndrome in a region of northeast Germany where Tula hantavirus circulates. J Clin Microbiol (2003) 1.25
Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. J Med Virol (2005) 1.18
Identification of ERp29, an endoplasmic reticulum lumenal protein, as a new member of the thyroglobulin folding complex. J Biol Chem (2002) 1.18
High HEV presence in four different wild boar populations in East and West Germany. Vet Microbiol (2009) 1.16
Hantavirus disease outbreak in Germany: limitations of routine serological diagnostics and clustering of virus sequences of human and rodent origin. J Clin Microbiol (2007) 1.13
Kinetic analyses of the surface-transmembrane disulfide bond isomerization-controlled fusion activation pathway in Moloney murine leukemia virus. J Virol (2005) 1.12
Versatile virus-like particle carrier for epitope based vaccines. PLoS One (2010) 1.12
Nuclear entry of hepatitis B virus capsids involves disintegration to protein dimers followed by nuclear reassociation to capsids. PLoS Pathog (2009) 1.10
Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection. Eur J Immunol (2012) 1.09
Hantavirus outbreak, Germany, 2007. Emerg Infect Dis (2008) 1.07
The fusion-controlling disulfide bond isomerase in retrovirus Env is triggered by protein destabilization. J Virol (2005) 1.07
The dynamic envelope of a fusion class II virus. Prefusion stages of semliki forest virus revealed by electron cryomicroscopy. J Biol Chem (2006) 1.07
Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus. J Clin Virol (2004) 1.07
Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients. Hepatology (2002) 1.04
In vivo protein cyclization promoted by a circularly permuted Synechocystis sp. PCC6803 DnaB mini-intein. J Biol Chem (2001) 1.03
A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice. Virol J (2010) 1.03
Development of virus-like particle technology from small highly symmetric to large complex virus-like particle structures. Intervirology (2013) 1.02
Site-specific labelling with a metal chelator for protein-structure refinement. J Biomol NMR (2004) 1.02
Activation of nitric oxide signaling by the rheumatoid arthritis shared epitope. Arthritis Rheum (2006) 1.01
Immune dysregulation by the rheumatoid arthritis shared epitope. J Immunol (2010) 1.00
Passive and active inclusion of host proteins in human immunodeficiency virus type 1 gag particles during budding at the plasma membrane. J Virol (2004) 1.00
Intersubunit disulfide isomerization controls membrane fusion of human T-cell leukemia virus Env. J Virol (2008) 0.99
The rheumatoid arthritis shared epitope increases cellular susceptibility to oxidative stress by antagonizing an adenosine-mediated anti-oxidative pathway. Arthritis Res Ther (2007) 0.99
Interactions between the transmembrane segments of the alphavirus E1 and E2 proteins play a role in virus budding and fusion. J Virol (2003) 0.98
Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model. Vaccine (2002) 0.98
Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses. J Immunol (2009) 0.98
N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus. J Hepatol (2010) 0.97
CTL escape mutations of core protein are more frequent in strains of HBeAg negative patients with low levels of HBV DNA. J Clin Virol (2009) 0.97
An outbreak of HBV and HCV infection in a paediatric oncology ward: epidemiological investigations and prevention of further spread. J Med Virol (2003) 0.96
High yields of stable and highly pure nucleocapsid proteins of different hantaviruses can be generated in the yeast Saccharomyces cerevisiae. J Biotechnol (2004) 0.96
Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent. J Gen Virol (2003) 0.95
Comparison of biomechanical and structural properties between human aortic and pulmonary valve. Eur J Cardiothorac Surg (2004) 0.94
Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles. Eur J Immunol (2005) 0.94
Dynamics of magnetotactic bacteria in a rotating magnetic field. Biophys J (2007) 0.93
Turning of the receptor-binding domains opens up the murine leukaemia virus Env for membrane fusion. EMBO J (2008) 0.93
Serological assays for the detection of human andes hantavirus infections based on its yeast-expressed nucleocapsid protein. Intervirology (2006) 0.93
Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen. Genet Vaccines Ther (2009) 0.93
A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice. PLoS One (2013) 0.92
Identification of the rheumatoid arthritis shared epitope binding site on calreticulin. PLoS One (2010) 0.92
Fatal reactivation of postnatal cytomegalovirus infection with rapid emergence of ganciclovir resistance in an infant after allogeneic stem cell transplantation. J Clin Microbiol (2005) 0.91
Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis. Proc Natl Acad Sci U S A (2002) 0.91
Acid-induced movements in the glycoprotein shell of an alphavirus turn the spikes into membrane fusion mode. EMBO J (2002) 0.90
Furin cleavage potentiates the membrane fusion-controlling intersubunit disulfide bond isomerization activity of leukemia virus Env. J Virol (2006) 0.90
Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes. Clin Vaccine Immunol (2010) 0.89
Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection. J Gen Virol (2004) 0.89
Maturation cleavage of the murine leukemia virus Env precursor separates the transmembrane subunits to prime it for receptor triggering. Proc Natl Acad Sci U S A (2012) 0.89
Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV). Vaccine (2006) 0.89
Development and evaluation of serological assays for detection of human hantavirus infections caused by Sin Nombre virus. J Clin Virol (2005) 0.89
Receptor-triggered but alkylation-arrested env of murine leukemia virus reveals the transmembrane subunit in a prehairpin conformation. J Virol (2006) 0.89
R-Peptide cleavage potentiates fusion-controlling isomerization of the intersubunit disulfide in Moloney murine leukemia virus Env. J Virol (2007) 0.89
Inhibition of the HIV-1 spike by single-PG9/16-antibody binding suggests a coordinated-activation model for its three protomeric units. J Virol (2013) 0.88
Nucleocapsid protein of cell culture-adapted Seoul virus strain 80-39: analysis of its encoding sequence, expression in yeast and immuno-reactivity. Virus Genes (2005) 0.88
Activation of the alphavirus spike protein is suppressed by bound E3. J Virol (2011) 0.87
Quantitative detection and typing of hepatitis D virus in human serum by real-time polymerase chain reaction and melting curve analysis. Diagn Microbiol Infect Dis (2010) 0.87
Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes. Intervirology (2002) 0.87
Prospective evaluation of the clinical utility of different methods for the detection of human cytomegalovirus disease after liver transplantation. Am J Transplant (2004) 0.86
The conserved His8 of the Moloney murine leukemia virus Env SU subunit directs the activity of the SU-TM disulphide bond isomerase. Virology (2006) 0.86
Stabilization of TM trimer interactions during activation of moloney murine leukemia virus Env. J Virol (2007) 0.86
The dynamic envelope of a fusion class II virus. E3 domain of glycoprotein E2 precursor in Semliki Forest virus provides a unique contact with the fusion protein E1. J Biol Chem (2008) 0.86
Genomic organization and promoter characterization of the gene encoding a putative endoplasmic reticulum chaperone, ERp29. Gene (2002) 0.85
Potato virus Y-like particles as a new carrier for the presentation of foreign protein stretches. Mol Biotechnol (2012) 0.85
An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice. Virology (2004) 0.85
Monoclonal antibodies providing topological information on the duck hepatitis B virus core protein and avihepadnaviral nucleocapsid structure. J Virol (2007) 0.84
Solution structure of the R3H domain from human Smubp-2. J Mol Biol (2003) 0.84
Cooperative cleavage of the R peptide in the Env trimer of Moloney murine leukemia virus facilitates its maturation for fusion competence. J Virol (2011) 0.84
Signal sequences modulate the immunogenic performance of human hepatitis C virus E2 gene. Mol Immunol (2006) 0.84
Preparation of hepatitis C virus structural and non-structural protein fragments and studies of their immunogenicity. Protein Expr Purif (2006) 0.84
High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers. Vaccine (2008) 0.81
Fibronectin-binding nanoparticles for intracellular targeting addressed by B. burgdorferi BBK32 protein fragments. Nanomedicine (2012) 0.81
Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris. Protein Expr Purif (2010) 0.81
NKT cells determine titer and subtype profile of virus-specific IgG antibodies during herpes simplex virus Infection. J Immunol (2014) 0.81